257 related articles for article (PubMed ID: 29449541)
1. Long noncoding RNA MEG3 suppresses liver cancer cells growth through inhibiting β-catenin by activating PKM2 and inactivating PTEN.
Zheng Q; Lin Z; Xu J; Lu Y; Meng Q; Wang C; Yang Y; Xin X; Li X; Pu H; Gui X; Li T; Xiong W; Lu D
Cell Death Dis; 2018 Feb; 9(3):253. PubMed ID: 29449541
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic silencing of miR-338 facilitates glioblastoma progression by de-repressing the pyruvate kinase M2-β-catenin axis.
Han B; Meng X; Chen H; Chen L; Liu X; Wang H; Liu D; Gao F; Lin L; Ming J; Sun B; Yin S; Wang R; Wu P; Cai J; Jiang C
Aging (Albany NY); 2017 Aug; 9(8):1885-1897. PubMed ID: 28858851
[TBL] [Abstract][Full Text] [Related]
3. Double mutant P53 (N340Q/L344R) promotes hepatocarcinogenesis through upregulation of Pim1 mediated by PKM2 and LncRNA CUDR.
Wu M; An J; Zheng Q; Xin X; Lin Z; Li X; Li H; Lu D
Oncotarget; 2016 Oct; 7(41):66525-66539. PubMed ID: 27167190
[TBL] [Abstract][Full Text] [Related]
4. Arsenic trioxide inhibits EMT in hepatocellular carcinoma by promoting lncRNA MEG3 via PKM2.
Fan Z; He J; Fu T; Zhang W; Yang G; Qu X; Liu R; Lv L; Wang J
Biochem Biophys Res Commun; 2019 Jun; 513(4):834-840. PubMed ID: 31003765
[TBL] [Abstract][Full Text] [Related]
5. Pyruvate kinase M2 prevents apoptosis via modulating Bim stability and associates with poor outcome in hepatocellular carcinoma.
Hu W; Lu SX; Li M; Zhang C; Liu LL; Fu J; Jin JT; Luo RZ; Zhang CZ; Yun JP
Oncotarget; 2015 Mar; 6(9):6570-83. PubMed ID: 25788265
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA HULC accelerates liver cancer by inhibiting PTEN via autophagy cooperation to miR15a.
Xin X; Wu M; Meng Q; Wang C; Lu Y; Yang Y; Li X; Zheng Q; Pu H; Gui X; Li T; Li J; Jia S; Lu D
Mol Cancer; 2018 Jun; 17(1):94. PubMed ID: 29895332
[TBL] [Abstract][Full Text] [Related]
7. The long noncoding RNA glycoLINC assembles a lower glycolytic metabolon to promote glycolysis.
Zhu Y; Jin L; Shi R; Li J; Wang Y; Zhang L; Liang CZ; Narayana VK; De Souza DP; Thorne RF; Zhang LR; Zhang XD; Wu M
Mol Cell; 2022 Feb; 82(3):542-554.e6. PubMed ID: 35081364
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA MEG3 promotes autophagy and apoptosis of nasopharyngeal carcinoma cells via PTEN up-regulation by binding to microRNA-21.
Lin L; Liu X; Lv B
J Cell Mol Med; 2021 Jan; 25(1):61-72. PubMed ID: 33332708
[TBL] [Abstract][Full Text] [Related]
9. PKM2 promotes glioma progression by mediating CTNNB1 expression.
Ma C; Feng Y; Zhong K; Wei J
Neurol Res; 2024 Jul; 46(7):583-592. PubMed ID: 38797679
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of pyruvate kinase M2 isoform inhibits cell motility in hepatocellular carcinoma cells.
Chen YL; Song JJ; Chen XC; Xu W; Zhi Q; Liu YP; Xu HZ; Pan JS; Ren JL; Guleng B
World J Gastroenterol; 2015 Aug; 21(30):9093-102. PubMed ID: 26290635
[TBL] [Abstract][Full Text] [Related]
11. LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2.
Jia G; Wang Y; Lin C; Lai S; Dai H; Wang Z; Dai L; Su H; Song Y; Zhang N; Feng Y; Tang B
J Exp Clin Cancer Res; 2021 Sep; 40(1):299. PubMed ID: 34551796
[TBL] [Abstract][Full Text] [Related]
12. lncRNA MEG3 Suppresses the Tumorigenesis of Hemangioma by Sponging miR-494 and Regulating PTEN/ PI3K/AKT Pathway.
Dai Y; Wan Y; Qiu M; Wang S; Pan C; Wang Y; Ou J
Cell Physiol Biochem; 2018; 51(6):2872-2886. PubMed ID: 30562741
[TBL] [Abstract][Full Text] [Related]
13. Long non‑coding RNA MEG3 inhibits cell migration and invasion of non‑small cell lung cancer cells by regulating the miR‑21‑5p/PTEN axis.
Lv D; Bi Q; Li Y; Deng J; Wu N; Hao S; Zhao M
Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33495842
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA HULC accelerates the growth of human liver cancer stem cells by upregulating CyclinD1 through miR675-PKM2 pathway via autophagy.
Wang C; Jiang X; Li X; Song S; Meng Q; Wang L; Lu Y; Xin X; Pu H; Gui X; Li T; Lu D
Stem Cell Res Ther; 2020 Jan; 11(1):8. PubMed ID: 31900225
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-induced lncRNA-AC020978 promotes proliferation and glycolytic metabolism of non-small cell lung cancer by regulating PKM2/HIF-1α axis.
Hua Q; Mi B; Xu F; Wen J; Zhao L; Liu J; Huang G
Theranostics; 2020; 10(11):4762-4778. PubMed ID: 32308748
[No Abstract] [Full Text] [Related]
16. PKM2 depletion induces the compensation of glutaminolysis through β-catenin/c-Myc pathway in tumor cells.
Wu H; Li Z; Yang P; Zhang L; Fan Y; Li Z
Cell Signal; 2014 Nov; 26(11):2397-405. PubMed ID: 25041845
[TBL] [Abstract][Full Text] [Related]
17. LncRNA MEG3 repressed malignant melanoma progression via inactivating Wnt signaling pathway.
Li P; Gao Y; Li J; Zhou Y; Yuan J; Guan H; Yao P
J Cell Biochem; 2018 Sep; 119(9):7498-7505. PubMed ID: 29781534
[TBL] [Abstract][Full Text] [Related]
18. IGF-1-mediated PKM2/β-catenin/miR-152 regulatory circuit in breast cancer.
Wen YY; Liu WT; Sun HR; Ge X; Shi ZM; Wang M; Li W; Zhang JY; Liu LZ; Jiang BH
Sci Rep; 2017 Nov; 7(1):15897. PubMed ID: 29162853
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of CREB binding protein-beta-catenin signaling down regulates CD133 expression and activates PP2A-PTEN signaling in tumor initiating liver cancer cells.
Tang Y; Berlind J; Mavila N
Cell Commun Signal; 2018 Mar; 16(1):9. PubMed ID: 29530069
[TBL] [Abstract][Full Text] [Related]
20. MEG3 interacted with miR-494 to repress bladder cancer progression through targeting PTEN.
Shan G; Tang T; Xia Y; Qian HJ
J Cell Physiol; 2020 Feb; 235(2):1120-1128. PubMed ID: 31294463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]